Tone mix
Week by week 51 weeks
Share of uniQure N.V.'s 410 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Aug 17, 2026 · tone +98uniQure (NASDAQ:QURE) Rating Increased to Hold at Wall Street Zen+91
- Week of Apr 20, 2026 · tone +67uniQure N.V. (QURE) Stock Posts 30% Growth from Last Year+78
- Week of Apr 27, 2026 · tone +80UniQure Advances Toward UK Filing For AMT-130 After Positive MHRA Pre-Submission Meeting; Stock Up+78
- Week of Nov 3, 2025 · tone -42uniQure (QURE) Price Targets Raised by Analysts After Positive Trial Results-77
- Week of Sep 1, 2025 · tone +99uniQure Inc.: uniQure Announces Initial AMT-191 Phase I/IIa Data Showing Sustained Increases in a-Gal A Enzyme Activity in Patients with Fabry Disease+69
- Week of Jul 27, 2026 · tone -25uniQure (NASDAQ:QURE) Releases Quarterly Earnings Results, Misses Expectations By $0.40 EPS-69
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about uniQure N.V. in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 9 | +22 |
| Last 30 sessions | 32 | -3 |
| Last 90 sessions | 52 | +2 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Thursday, November 5, 2026
3 headlines, average tone +33: 1 positive, 2 neutral and 0 negative. Showing all 3.
- www.themarketsdaily.com · 1 outletuniQure (NASDAQ:QURE) Releases Earnings Results, Beats Estimates By $0.04 EPSPositive
- www.pharmaceutical-business-review.com · 1 outletFDA to review uniQure's BLA for Huntington's gene therapyNeutral
- www.fool.com · 1 outletuniQure (QURE) Q3 2026 Earnings Call TranscriptNeutral
Show the table · 3 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| uniQure (NASDAQ:QURE) Releases Earnings Results, Beats Estimates By $0.04 EPS | www.themarketsdaily.com | 1 | Positive |
| FDA to review uniQure's BLA for Huntington's gene therapy | www.pharmaceutical-business-review.com | 1 | Neutral |
| uniQure (QURE) Q3 2026 Earnings Call Transcript | www.fool.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, November 4, 2026
4 headlines, average tone +24: 1 positive, 3 neutral and 0 negative. Showing all 4.
- www.biopharmadive.com · 1 outletUniQure gets an FDA decision date; Teva scraps brain drug studyPositive
- www.manilatimes.net · 1 outletuniQure Announces Third Quarter 2026 Financial Results and Provides Company UpdateNeutral
- www.finanznachrichten.de · 1 outletuniQure Inc.: uniQure Announces Third Quarter 2026 Financial Results and Provides Company UpdateNeutral
- www.dailypolitical.com · 1 outletuniQure (QURE) Set to Post Earnings on WednesdayNeutral
Show the table · 4 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| UniQure gets an FDA decision date; Teva scraps brain drug study | www.biopharmadive.com | 1 | Positive |
| uniQure Announces Third Quarter 2026 Financial Results and Provides Company Update | www.manilatimes.net | 1 | Neutral |
| uniQure Inc.: uniQure Announces Third Quarter 2026 Financial Results and Provides Company Update | www.finanznachrichten.de | 1 | Neutral |
| uniQure (QURE) Set to Post Earnings on Wednesday | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, November 3, 2026
1 headline, average tone -100: 0 positive, 0 neutral and 1 negative. Showing all 1.
- www.investors.com · 1 outletUniqure Stock Falls After Its Huntington's Gene Therapy Lands At The FDANegative
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Uniqure Stock Falls After Its Huntington's Gene Therapy Lands At The FDA | www.investors.com | 1 | Negative |
No matching rows. Clear the filter to see all records.
Headlines on Monday, November 2, 2026
1 headline, average tone +100: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.manilatimes.net · 1 outletuniQure Announces FDA Acceptance and Priority Review of the Biologics License Application for ifezuntirgene inilparvovec for the Treatment of Huntington's DiseasePositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| uniQure Announces FDA Acceptance and Priority Review of the Biologics License Application for ifezuntirgene inilparvovec for the Treatment of Huntington's Disease | www.manilatimes.net | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 28, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.manilatimes.net · 1 outletuniQure to Announce Third Quarter 2026 Financial ResultsNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| uniQure to Announce Third Quarter 2026 Financial Results | www.manilatimes.net | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about uniQure N.V., not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.